Marksans Pharma Ltd (BOM:524404)
₹ 298.6 -2.75 (-0.91%) Market Cap: 135.68 Bil Enterprise Value: 131.12 Bil PE Ratio: 40.62 PB Ratio: 6.57 GF Score: 85/100

Q1 2023 Marksans Pharma Ltd Earnings Call Transcript

Aug 16, 2022 / 12:00PM GMT
Release Date Price: ₹52.95 (+6.33%)
Operator

Good evening, ladies, and gentlemen. I'm Kritika, moderator of Marksans Pharma Q1 FY'23 Earnings Call hosted by DAM Capital Advisors Limited. (Operator Instructions)

Please note this conference is recorded. I would now like to hand over the floor to Mr. Nitin Agarwal of DAM Capital. Thank you and over to you, Sir.

Nitin Agarwal
DAM Capital Advisors Ltd - Analyst

Thanks, moderator. Good evening, everyone, and a very warm welcome to Marksans Pharma Limited Q1 FY'23 post results earnings call hosted by DAM Capital Advisors.

On the call today we have representing Marksans Pharma management, Mr. Mark Saldanha, Founder, Chairman and Managing Director, and Mr. Jitendra Sharma, Chief Financial Officer. I'll hand over the call to Mark to make the opening comments and then we'll open the floor for Q&A. Please go ahead, Mark.

Mark Saldanha
Marksans Pharma Ltd - Founder, Chairman & Managing Director

Thank you, Nitin. Welcome everyone to our Q1 FY'23 earnings call. I'm pleased to share that we had a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot